OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 81 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.88 and the average weighting 0.4%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$476,000,00075,0000.01%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,595,484$5,710,0004.85%
Cypress Capital Management LLC (WY) 321,725$708,0000.74%
Noven Financial Group, Inc. 103,964$229,0000.12%
Transform Wealth, LLC 205,481$452,0000.08%
Cutter & CO Brokerage, Inc. 50,000$110,0000.04%
TRUSTCORE FINANCIAL SERVICES, LLC 44,500$98,0000.04%
GHP Investment Advisors, Inc. 100,000$220,0000.03%
BRIGHTON JONES LLC 85,555$188,0000.02%
Valeo Financial Advisors, LLC 330,000$155,0000.02%
TRUSTCORE FINANCIAL SERVICES, LLC 27,348$60,0000.02%
View complete list of AMPIO PHARMACEUTICALS INC shareholders